We show that MNA neuroblastoma is sensitized to PRMT5 inhibition in vitro and in vivo, adding to the recent evidence for the spliceosomal vulnerability of neuroblastoma [27,28,46, 47]. Here, PRMT5 is linked to neuroblastoma.